Dare Bioscience, Inc. ·

DARE 8-K 2026-10-02

Dare Bioscience, Inc. (DARE) 8-K dated 2026-10-02 — accession 0001401914-26-000052. This URL is the filing, not the DARE hub.

Dare Bioscience, Inc. (DARE) is a biotechnology company listed on US.

Dare Bioscience, Inc. filed a 8-K on 2026-10-02. Accession 0001401914-26-000052.

Cached items: 3.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported DARE revenue for 2025-12-31 was $1.0M. Net income was -$13.4M. Revenue was up 10429.4% from 2024-12-31 to 2025-12-31. DARE currently screens at market cap $21.2M.

Not investment advice. The DARE SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR

Lician Pro $19.99/mo or $149/yr